ARCHIVES

NCI, FDA Are Feuding Again, This Time Overcharge That DCT Moved Too Slowly On Toxicity Notification

This article is from The Cancer Letter archive.

Vol. 07 No. 15 | April 10, 1981

Download PDF Visit The Full Archive

Related Articles

MSK, Fox Chase Volunteer to Limit Their Core Grants To Let Others Grow

June 29, 1990

$2-A-Pack Cigarette Tax A “Significant Deterrent,” NCAB Resolution Says

October 8, 1993

No Protective Effect From Long-Term Vitamin E or C

November 28, 2008

Society Support Program for Training Cytotechnologists

November 29, 1991

NCI Viewed As NIH’s ‘Administrative Reserve,” Broder Tells Directors

July 12, 1991

FDA Approves Avastin Combination For Late-Stage Cervical Cancer

August 29, 2014